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Background: Prevalence rates for Atopic Dermatitis (AD) vary from country to country and
there are substantial differences between regions on the same continent. Environmental
factors play a role in this variation; these factors seem to be related to socioeconomic dif-
ferences. In China, low prevalences have been reported, contrasting sharply with the high
prevalences in nearby Japan. China is currently in a rapid transformation, driven by a high
rate of economic growth. The onset of this growth was earlier in the large cities.
Objective: To obtain reliable age specific estimates of the prevalence of AD in a rural and an
urban environment, to test whether there are differences, and to check whether these dif-
ferences are related to different patterns of immunisation, allergic history and family income.
Methods: A (cluster) sample was drawn from kindergartens and primary schools in Tianjin
city, and in a rural district outside Tianjin. The total sample included 4483 children. Ques-
tionnaires based on the ISAAC questionnaire were via the teachers distributed to the children.
If the returned questionnaire indicated the presence of AD, this was verified by a derma-
tologist.
Results: With 3708 returned questionnaires the response rate was almost 83%. The crude
prevalence in 1–6 yr olds was 2.9%. Age specific prevalences ranged between 1.7 and 4.8%.
Prevalence in the city was 2.4%, while the rural prevalence was 3.5%. Prevalence was not
associated with immunizations, family size or family income, while a history of childhood
diseases appeared to be a contributing factor.
Conclusions: The prevalence in this region in China is relatively low, without differences
between city and rural area. Apparently, the anticipated transition to higher prevalence has
not yet taken place. Cohort studies may give an opportunity to study the risk factors that are
associated with the anticipated rise in prevalence.
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Objectives: To describe the occurrence and risk of psoriasis in Norwegian twins and to
explore age and sex specific characteristics of the disease.
Methods: In 1998 the National Institute of Public Health in Oslo conducted a population-
based health survey among Norwegian twins born between 1967 and 1979. This historical
cohort consists of more than 12 000 twins identified through the national Medical Birth
Registry. We have analyzed the self-reported history of psoriasis among the 8045 question-
naire responders.
Results: Altogether, 334 (4.2%) individuals reported a positive history of psoriasis. The
overall prevalence rates were similar in females and males. However, the point prevalences in
the teenage four-year intervals were significantly higher in females. A nearly linear increase in
incidence rates was observed for both females and males but peaked at different ages. Sex
differences emerged in the absolute risks of developing psoriasis across the whole age
distribution, but by the age of 31 the cumulative incidence was similar in both sexes. Mean
age at onset of the disease was significantly lower in females than in males (14.8 years and
17.3 years, respectively).
Conclusions: We have found a high prevalence of psoriasis in this historical cohort of twins
aged 19-31 years. The observed sex disparity in the natural history of psoriasis will be
elucidated. Methodological considerations will be discussed.
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Objectives: To develop an accepted evidence-based guideline for the treatment of plaque
psoriasis in Germany.
Methods: In a first step systematic search for existing evidence based clinical guidelines for
plaque psoriasis was performed in the G.I.N. database and other sources. Based on these
results the guideline protocol was developed. The base of the guideline project will be an
extensive systematic search of the databases MedLine, Embase and the Cochrane library.
The literature will be critically appraised by a group of 10 (5þ 5 group) dermatologists (5 from
university hospitals and 5 from private practices). The 5þ 5 group will formulate a first version
of the guidelines, which will be discussed in the extended guideline group that will include
other specialists as well as patients. The project will be supported by the Deutsche De-
rmatologische Gesellschaft (DDG) as well as the Berufsverband Deutscher Dermatologen
(BVDD) (the German organisations for dermatologists in hospitals and private practices).
Results: The G.I.N. database research revealed several guidelines. Among those the Dutch
guideline ‘‘Photo(chemo)therapy and systemic therapy for severe chronically plaque type
psoriasis’’ was found to serve as a good base for the German guideline. The methodology of
the Dutch guidelines will be adapted. The German guideline project started in the beginning
of 2004. The first 5þ 5 meeting will take place at the end of June 2004. The aim of this
meeting will be critical appraise the Dutch guidelines and familiarize the 5þ 5 group with the
critical appraisal of the literature and the verbalisation of the guideline.
Conclusions: There is a strong need for developing broadly accepted evidence based
guideline for common diseases like plaque psoriasis. So far the development of guidelines is
mostly limited to specific countries. Although in Europe national differences in patient care as
well as in therapy preferences may differ significantly, an international cooperation of guide-
line groups should be attempted with the final aim to create a European Guidelines.
10. SELF-REPORTED ITCH AND MENTAL HEALTH. A NORWEGIAN SURVEY AMONG
ADULTS
Florence Dalgard, A˚ke Svensson,w Jan Øivind Holm,z Johanne Sundby,y Odd Steffen Da-
lgardz
Institute of General Practice and Preventive Medicine, Norway; wMalm Universitets
sykehus, Sweden; zUlleva˚l Sykehus, Norway; yInstitute of General Practice and Community
Medicine, Norway; zInstitute of General Practice and Community Medicine, Norway
Background: Itch is a symptom common to several chronic skin diseases and frequently
encountered in the dermatological consultation. Unlike other dermatological visible symp-
toms itch is subjective and often challenging for clinicians.
Objective: The aim of this study was to describe the prevalence of self-reported itch and to
analyse the associations of itch with psycho-social factors in the general population.
Materials and Methods: The method used was a questionnaire on self- reported skin com-
plaints. It was previously developed and validated. The design of the study was cross sec-
tional. 40 888 in the city of Oslo, in age groups 30, 40, 45, 60 and 75 received a postal
questionnaire. It included questions on self- reported health, and psycho-social factors as
mental distress, negative life events and social network. 18 770 responded, thereby obtaining
a response rate of 46%. A non responder study has been conducted.
Summary of Results: In this urban population the prevalence of itch among adults 8.4%
and of mental distress 11.2%. Among the mental distressed 15.9% itch quite a lot and very
much compared to 7.5% of the non mental distressed. In a logistic regression model for each
gender separately the odds ratios for itch was 1.81 (1.33; 2.46) for men and 1.39 (1.07; 1.81)
for women when having experienced more than two negative life events. Further the odds
ratios for itch when mentally distressed was 1.81 (1.21; 2.70) for men and 1.94 (1.47; 2.55) for
women. In an adjusted model for mental distress the odds ratios for itch was 1.70(1.12; 2.57)
for men and 1.82 (1.37; 2.42) for women for itching quite a lot or very much.
Conclusions: This study showed that the symptom itch is common in the community and
that there is a strong association between self-reported itch and psycho-social factors in the
general population. These findings should be retained in the dermatological consultation.
11. THE MEANING OF SKIN DISEASE: THE IMPORTANCE OF QUALITATIVE RESEARCH
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Skin disease has meanings, which derive from social & cultural understandings, which are of
course informed in the contemporary world by scientific & professional research & knowl-
edge. But the latter do not by any means wholly determine popular beliefs and perceptions at
the level of the general public, nor at the level of the individual who has such disease. These
meanings are often longstanding, constantly reinforced & amplified, continuing & in force
even in the face of calculated rational efforts to counter them.
In consequence, behaviour rests upon preconceptions, beliefs and values, which can be at
odds with the notions & goals underpinning professional therapeutic decisions for example,
not uncommonly undermining them. Treatment itself is a challenge to understanding, with
‘‘meanings’’ to be determined & unravelled by the patient & the wider community alike. Nor
should it be thought that medical & related concepts, knowledge & practise are insulated
from wider cultural conceptions. The EDEN Network findings & others provide ample evi-
dence that clinical decisions are influenced, even founded upon, considerations other than
scientifically grounded evidence & support. They include ‘‘tradition’’, custom & practice,
personal preference, commercial/promotional influence, & political considerations & con-
straints.
It is easy to make the mistake of ignoring such realities, failing to take lay, ‘‘folk’’ or ‘‘ver-
nacular’’ understandings, concerns & behavioural practices seriously; & to dismiss them as
simply irrelevant, or falsely founded & problematic, requiring no more than ‘‘correction’’.
Recent enthusiasm for cognitive & behavioural intervention as a component of treatment
reflects in some measure a drive to secure patient ‘‘pacification’’, & behavioural compliance
with the specifics of a therapeutic regime, without any serious attempt to understand the
complexity of the social ‘‘world’’ within which the patient operates & the justifiable broader
goals & constraints which influence, even direct, him/her. ‘‘Chronicity’’ is a central feature of
that experience & the enduring everyday reality which has to be addressed by the patient, his
supporters, & those with whom he has wider social encounters. It should not be ignored by
the professional who has been consulted.
The meaning of skin disease in this wider sense is unlikely to be revealed by means of
investigative instruments designed for, & more suited to, quantitative research. An approach
akin to the natural observational, ethnographic, interpretive field research traditions of social
anthropology and qualitative sociology is more likely to bring useful knowledge & under-
standing. We know, & give explicit recognition to, all too little of what people actually ‘‘do’’ &
don’t do, & the rationale for it, in relation to their disease & treatment. We have no sound basis
in descriptive fact, nor much by way of a framework for understanding & interpretation of
dermatological illness behaviour. Thus far the approach of Dermatologists to ‘‘disability, &
their understanding of it, has lagged behind that of colleagues in other specialties. This has
made their well-motivated efforts to deal with it individually & collectively less effective than
they should & could have been.
The evidence or ‘‘data’’ in enquiry designed to explore all this will be ‘‘soft’’ rather than
‘‘hard’’, but deserve to be taken seriously nonetheless. Such a concern for uncovering
meaning imbedded in culture & everyday social organization will inevitably too, shift at least
some of the attentions of dermatologists away from sole & precise focus upon individuals, the
skin itself as an organ, & diseases afflicting it, to encompass the meaning of dermatological
disease & its management for the community and the wider public, as crucial to their pro-
fessional concerns. It makes more likely & more genuinely effective moreover, the ‘‘conver-
sation’’ with patients & their representatives, in striving for concordance in therapy at an
individual level; & at a collective level, partnership in joint ‘‘political’’ activity directed towards
countering prejudice & discrimination, securing appropriate resourcing, & improving quality of
life, public health & the general well-being.
If the everyday world of the individual with skin disease is seen & understood in a broader
cultural & social context, then Clinical Dermatology could be reshaped to include at its heart
genuine community engagement. The first step may be to recognise the value of qualitative
research which could inform a more comprehensive & better understanding of the fact that
there is more to skin disease than simply disease of the skin.
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